S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
Sell every Stock except ONE (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
Sell every Stock except ONE (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
Sell every Stock except ONE (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
Sell every Stock except ONE (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
NASDAQ:SIBN

SI-BONE (SIBN) Stock Forecast, Price & News

$24.27
-0.27 (-1.10%)
(As of 05/26/2023 04:00 PM ET)
Compare
Today's Range
$24.07
$24.67
50-Day Range
$19.28
$26.49
52-Week Range
$11.14
$27.24
Volume
202,100 shs
Average Volume
331,633 shs
Market Capitalization
$853.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.29

SI-BONE MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
4.2% Upside
$25.29 Price Target
Short Interest
Healthy
2.24% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.44
Upright™ Environmental Score
News Sentiment
1.49mentions of SI-BONE in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$7.45 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.44) to ($1.26) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.37 out of 5 stars

Medical Sector

268th out of 1,010 stocks

Surgical & Medical Instruments Industry

27th out of 104 stocks


SIBN stock logo

About SI-BONE (NASDAQ:SIBN) Stock

SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 2008 and is headquartered in Santa Clara, CA.

Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

SIBN Stock News Headlines

Free A.I. Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Free A.I. Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
SI-BONE (NASDAQ:SIBN) Shares Gap Up on Analyst Upgrade
SI-BONE (NASDAQ:SIBN) Reaches New 1-Year High at $22.73
Why Shares of Si-Bone Jumped Tuesday
SI-BONE (SIBN) Set to Announce Earnings on Monday
Analysts Set SI-BONE, Inc. (NASDAQ:SIBN) Target Price at $24.63
See More Headlines
Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

SIBN Company Calendar

Last Earnings
11/08/2021
Today
5/29/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SIBN
Fax
N/A
Employees
352
Year Founded
2008

Price Target and Rating

Average Stock Price Forecast
$25.29
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+4.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-61,260,000.00
Pretax Margin
-47.11%

Debt

Sales & Book Value

Annual Sales
$106.41 million
Book Value
$2.85 per share

Miscellaneous

Free Float
33,284,000
Market Cap
$853.82 million
Optionable
Not Optionable
Beta
0.95

Social Links


Key Executives

  • Laura A. FrancisLaura A. Francis
    Chief Executive Officer & Director
  • Anshul Maheshwari
    Chief Financial & Accounting Officer
  • Scott A. Yerby
    Chief Technology Officer & Senior VP-Engineering
  • W. Carlton Reckling
    Chief Medical Officer & VP-Medical Affairs
  • Joyce Goto
    Vice President & Controller













SIBN Stock - Frequently Asked Questions

Should I buy or sell SI-BONE stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SI-BONE in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SIBN shares.
View SIBN analyst ratings
or view top-rated stocks.

What is SI-BONE's stock price forecast for 2023?

7 Wall Street research analysts have issued 12 month price objectives for SI-BONE's shares. Their SIBN share price forecasts range from $20.00 to $32.00. On average, they predict the company's share price to reach $25.29 in the next year. This suggests a possible upside of 4.2% from the stock's current price.
View analysts price targets for SIBN
or view top-rated stocks among Wall Street analysts.

How have SIBN shares performed in 2023?

SI-BONE's stock was trading at $13.60 at the beginning of 2023. Since then, SIBN stock has increased by 78.5% and is now trading at $24.27.
View the best growth stocks for 2023 here
.

Are investors shorting SI-BONE?

SI-BONE saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 786,800 shares, a decrease of 28.5% from the April 30th total of 1,100,000 shares. Based on an average daily trading volume, of 395,700 shares, the short-interest ratio is presently 2.0 days.
View SI-BONE's Short Interest
.

When is SI-BONE's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our SIBN earnings forecast
.

How were SI-BONE's earnings last quarter?

SI-BONE, Inc. (NASDAQ:SIBN) announced its earnings results on Monday, November, 8th. The company reported ($0.48) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by $0.06. The company earned $22.29 million during the quarter, compared to the consensus estimate of $22.71 million. SI-BONE had a negative net margin of 47.11% and a negative trailing twelve-month return on equity of 54.17%. During the same period in the previous year, the business posted ($0.33) earnings per share.

What guidance has SI-BONE issued on next quarter's earnings?

SI-BONE issued an update on its FY 2023 earnings guidance on Monday, May, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $128.00 million-$131.00 million, compared to the consensus revenue estimate of $125.45 million.

What is Jeffrey Dunn's approval rating as SI-BONE's CEO?

10 employees have rated SI-BONE Chief Executive Officer Jeffrey Dunn on Glassdoor.com. Jeffrey Dunn has an approval rating of 41% among the company's employees. This puts Jeffrey Dunn in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of SI-BONE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-BONE investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), Raytheon Technologies (RTX), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO) and CSX (CSX).

When did SI-BONE IPO?

(SIBN) raised $84 million in an IPO on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is SI-BONE's stock symbol?

SI-BONE trades on the NASDAQ under the ticker symbol "SIBN."

Who are SI-BONE's major shareholders?

SI-BONE's stock is owned by many different institutional and retail investors. Top institutional shareholders include Brown Advisory Inc. (11.24%), BlackRock Inc. (7.82%), First Light Asset Management LLC (6.01%), Champlain Investment Partners LLC (4.85%), Granahan Investment Management LLC (3.35%) and Next Century Growth Investors LLC (3.23%). Insiders that own company stock include Anshul Maheshwari, Anthony J Recupero, Anthony J Recupero, Gregory K Hinckley, Jeffrey W Dunn, Jeffrey W Dunn, Jeryl L Hilleman, Jeryl L Hilleman, John Gordon Freund, Laura Francis, Michael A Pisetsky and Michael A Pisetsky.
View institutional ownership trends
.

How do I buy shares of SI-BONE?

Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SI-BONE's stock price today?

One share of SIBN stock can currently be purchased for approximately $24.27.

How much money does SI-BONE make?

SI-BONE (NASDAQ:SIBN) has a market capitalization of $853.82 million and generates $106.41 million in revenue each year. The company earns $-61,260,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis.

How many employees does SI-BONE have?

The company employs 352 workers across the globe.

Does SI-BONE have any subsidiaries?
The following companies are subsidiares of SI-BONE: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD.
Read More
How can I contact SI-BONE?

SI-BONE's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The official website for the company is www.si-bone.com. The company can be reached via phone at (408) 207-0700 or via email at investors@si-bone.com.

This page (NASDAQ:SIBN) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -